Evidence map›Paper›PMID 28705201›Full record

ArticleBMC research notes2017

Genotypic diversity among multidrug resistant Pseudomonas aeruginosa and Acinetobacter species at Mulago Hospital in Kampala, Uganda.

David P Kateete, Ritah Nakanjako, Moses Okee, Moses L Joloba, Christine F Najjuka

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Proportions ofOpen forum infectious diseases · 2024
    Article
  7. Article
  8. Article
  9. DiarrhoeagenicAfrican health sciences · 2022
    Article
  10. Review
  11. Article
  12. Antibiotic-ResistantAntibiotics (Basel, Switzerland) · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. blaBMC infectious diseases · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

David P KateeteDepartment of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala, Uganda. dkateete@chs.mak.ac.ug.
Ritah NakanjakoDepartment of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala, Uganda.
Moses OkeeDepartment of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala, Uganda.
Moses L JolobaDepartment of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala, Uganda.
Christine F NajjukaDepartment of Medical Microbiology, College of Health Sciences, Makerere University, Kampala, Uganda. najjukafc@gmail.cm.
Makerere University · UG

Funding

CELL TO CELL SIGNALING IN MYCOBACTERIAR01AI075637 · NIAID · MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES · PI JOLOBA, MOSES LUTAAKOME · 2007 to 2010
$319k
ROLE OF RHOMBOID HOMOLOGUES IN MYCOBACTERIA SIGNALINGR03AI062849 · NIAID · MAKERERE MEDICAL SCHOOL · PI JOLOBA, MOSES LUTAAKOME · 2005 to 2006
$107k
NIAID NIH HHS R01 AI075637NIAID NIH HHS R03 AI062849
6 · The paper itself

Abstract

backgroundMultidrug resistant Pseudomonas aeruginosa and Acinetobacter species are common causes of nosocomial infections worldwide. Recently we reported the occurrence of carbapenem resistant Enterobacteriaceae, P. aeruginosa and Acinetobacter species at Mulago National Referral Hospital in Kampala, Uganda, but the isolates were not analyzed for genetic relatedness. Herein we report the intra-species genotypic diversity among P. aeruginosa and Acinetobacter baumannii isolated from hospitalized patients and the environment at Mulago Hospital, using repetitive elements-based PCR (Rep-PCR) genotyping.

resultsA total of 736 specimens from hospitalized patients were processed for culture and sensitivity testing yielding 9 (1.2%) P. aeruginosa and 7 (0.95%) A. baumannii. Similarly, 100 samples from the hospital environment were processed yielding 33 (33%) P. aeruginosa and 13 (13%) A. baumannii. Altogether, 62 non-repetitive isolates were studied (42 P. aeruginosa and 20 A. baumannii), of which 38% (16/42) P. aeruginosa and 40% (8/20) A. baumannii were multidrug resistant (isolates resistant to three or more classes of antimicrobials). Carbapenem resistance prevalence was 33 and 21% for P. aeruginosa from patients and the environment, respectively, while it was 14 and 86% for A. baumannii from patients and environment, respectively. Cluster analysis of the Rep-PCR fingerprints revealed a high level of genetic diversity among the isolates within each species as few isolates were clustered (at 100% level of similarity). More to this, the clustered isolates revealed a complex nature of multidrug resistant P. aeruginosa and A. baumannii clones circulating at Mulago Hospital. Importantly, certain isolates from the environment and patients were clustered, implying that hospitalized patients at Mulago were probably infected with strains from the environment.

conclusionsThe prevalence of multidrug resistant P. aeruginosa and A. baumannii is high at Mulago Hospital but carbapenem resistance prevalence remains relatively low in isolates from hospitalized patients. Importantly, the prevalence of carbapenem resistance in isolates from the environment is high implying the infection control practices at the hospital might be inadequate.

Indexed as

Genetic VariationHospitalsAcinetobacter baumanniiAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialGenotypeHumansMicrobial Sensitivity TestsPhylogenyPseudomonas aeruginosaUgandaAnti-Bacterial AgentsAntimicrobial resistance AMRCarbapenemsGenotypingGram negative bacteriaHospital environmentHospitalized patientsRep-PCRSub-Saharan Africa

Identifiers

PMID28705201
PMCPMC5513047
OpenAlexW2734989370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.